<DOC>
	<DOC>NCT00385450</DOC>
	<brief_summary>In previous studies, 90% of patients who underwent elective cardiopulmonary bypass procedure manifested CD4 counts of less than 500 cells/microliter in the immediate (day 1) post-operative period. This study will investigate whether or not Nelfinavir increases those CD4 counts in the post-operative period.</brief_summary>
	<brief_title>Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor</brief_title>
	<detailed_description>See Brief Summary.</detailed_description>
	<mesh_term>Lymphopenia</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Any patient undergoing elective (nonemergency) cardiopulmonary bypass for coronary artery bypass grafting, cardiac valve replacement, or both. A dozen different medical conditions and two dozen medical contraindications.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>